Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BTT1023 (Timolumab) in Primary Sclerosing Cholangitis
NCT02239211Phase 2Completed
- Sponsor
- University of Birmingham
- Start
- Sep 2015
- Primary completion
- Oct 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of timolumab in Primary Sclerosing Cholangitis (PSC), sponsored by University of Birmingham. Started Sep 2015; status: completed.
02
Drugs
timolumab
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT02239211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02239211.